This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Oncocyte Corporation
Q22023
8/10/2023
Anthony
Conference Operator
Ladies and gentlemen, thank you for standing by. The conference will begin shortly. Please continue to hold and thank you for your patience.
Unidentified Participant
Thank you.
Anthony
Conference Operator
And welcome to the OncoSite Q2 2023 earnings call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, press star then one on your touchtone phone. To withdraw from the question queue, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Stephanie Prince from PCG Advisory. Please go ahead.
You're reading a preview of the OCX Q2 2023 earnings call.
Free account.
Disclaimer